Zobair Younossi MD, MPH, FACG, FACP, AGAF, FAASLD

Zobair M. Younossi, MD, MPH, is the Professor and Chairman of the Global NASH/MASH Council (GNC) in Washington, DC. Dr. Younossi earned his medical degree from the University of Rochester School of Medicine (Alpha Omega Alpha, 1989) and completed his postgraduate training (medicine, gastroenterology, and hepatology) at Scripps Clinic and Research Foundation, while earning his Master of Public Health degree with multiple honours (Hanlon Award and Outstanding Student Award) from San Diego State University.

He is the current President and Chairman of the Board of Trustees of the Chronic Liver Disease Foundation (CLDF, 2018-Present). He has served as the Chairman, Department of Medicine, Inova Fairfax Medical Campus (2011-2024) and the President of Inova Medicine (2019-2024). He has also served as the Vice President of Research for Inova Health System (2007-2018), the Chairman of Clinical Research for Inova Health System (2019-2022), and Vice Chair of Inova Health Foundation Board of Trustees (2008-2023), as well as a member of the Board of the American College of Gastroenterology Institute. He has represented the American Association of Liver Disease and the American Gastroenterological Association at different congressional meetings.

He has over 30 years of pioneering research in the field of MASLD (previously known as NAFLD) and outcomes research in liver disease, including health-related quality of life and other patient-reported outcomes (PROs) research and health economics of MASLD and other liver diseases. He has authored almost 900 articles, over 1100 abstracts, 3 books, 7 journal supplements, 26 book chapters, delivered over 550 faculty lectures with an H-index of 156 (Google Scholar) and 160,116 citations. He is ranked as the most cited scholar in Liver Disease and NAFLD/MASLD according to Scholar GPS-2022, 2024, and 2025.